Evaluation of the impact of the disruptions in KP activity on the pathogenesis of various neurological and psychiatric diseases will allow for a better understanding of their pathophysiology and the development of novel, effective therapeutic solutions. The gene discussed is NPPA; the disease is psychiatric disorder.